NOV 06, 2020 7:43 PM PST

Daily Aspirin Users Less Likely to Die From COVID-19

WRITTEN BY: Carmen Leitch

Recent work has backed up research from earlier this year that suggested that aspirin might help reduce the chance that a case of COVID-19 will be deadly. Scientists at the University of Maryland Baltimore School of Medicine (UMSOM) determined that people who take low-dose aspirin daily were significantly less likely to need to be admitted to the intensive care unit (ICU), and had better chances of surviving their illness than people that did not take aspirin. The findings, which have been reported in the journal Anesthesia and Analgesia, could enable clinicians to advise some people on how to avoid the worst cases of COVID-19.

Colorized scanning electron micrograph of an apoptotic cell (red) infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland./Credit: NIAID

“This is a critical finding that needs to be confirmed through a randomized clinical trial,” said study leader Jonathan Chow, M.D., an assistant professor of anesthesiology at UMSOM. “If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients.”

In this study, the researchers mined the records of 412 people that were hospitalized at one of three hospitals on the East Coast over the past few months with a case of COVID-19. About a quarter of the patients, who had an average age of 55, were taking low-dose aspirin every day to manage cardiovascular disease.

For those on daily aspirin, ICU admission and mechanical ventilators were about 43 percent less likely,  and there was a 47 percent reduction in the risk of death. People taking aspirin also did not have any increase in medical problems like bleeding. The researchers controlled for a variety of factors including age, health, and body mass index.

COVID-19 has been associated with the formation of blood clots all over the vasculature, including vessels in the lungs and heart. These clots may go on to cause other complications like stroke, which may lead to organ failure or death. While low-dose daily aspirin regimens are often recommended for people that have recovered from a stroke or heart attack, this daily intake of aspirin can also raise the risk of bleeding in some people.

“We believe that the blood-thinning effects of aspirin provide benefits for COVID-19 patients by preventing microclot formation,” said study co-author Michael A. Mazzeffi, M.D., an associate professor of anesthesiology at UMSOM. “Patients diagnosed with COVID-19 may want to consider taking a daily aspirin as long as they check with their doctor first.”

People with health issues like kidney disease, or those on medications like blood thinners, might not be able to take aspirin, he noted.

Sources: University of Maryland Baltimore School of Medicine, Anesthesia and Analgesia

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 26, 2021
Earth & The Environment
Glomalin, The Protein that Can Heal the Earth
OCT 26, 2021
Glomalin, The Protein that Can Heal the Earth
Soil quality is growing ever more important as we attempt to feed the growing world population. Our soils are being degr ...
NOV 14, 2021
Microbiology
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
NOV 14, 2021
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
Researchers have identified bacteria that have the potential to fight infections that affect the middle ear and can caus ...
NOV 29, 2021
Microbiology
How the Hepatitis B Virus Promotes Liver Cancer Development
NOV 29, 2021
How the Hepatitis B Virus Promotes Liver Cancer Development
It's estimated that about 240 million people worldwide have an HBV infection. Hepatitis B infections are linked to t ...
DEC 09, 2021
Microbiology
Microplastics Promote Antibiotic Resistance
DEC 09, 2021
Microplastics Promote Antibiotic Resistance
Microplastics pose a clear threat to the environment. They have been found nearly everywhere, from remote areas like the ...
DEC 21, 2021
Microbiology
Microbial Life Shows Mass Extinction Really Stinks
DEC 21, 2021
Microbial Life Shows Mass Extinction Really Stinks
There have been a few mass extinction events on our planet. One of them was apparently prolonged by microbes that were s ...
JAN 17, 2022
Microbiology
Research Suggests Epstein Barr Virus Can Cause Multiple Sclerosis
JAN 17, 2022
Research Suggests Epstein Barr Virus Can Cause Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease that impacts nearly 3 million people around the world. The cause ...
Loading Comments...